Last reviewed · How we verify

Mineral trioxide aggregate — Competitive Intelligence Brief

Mineral trioxide aggregate (Mineral trioxide aggregate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Dentistry/Endodontics.

marketed Dentistry/Endodontics Small molecule Live · refreshed every 30 min

Target snapshot

Mineral trioxide aggregate (Mineral trioxide aggregate) — Universidad de los Andes, Chile. Mineral trioxide aggregate (MTA) is a biocompatible cement that sets through a hydration reaction, creating a hard matrix that seals and promotes healing in endodontic and dental applications.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Mineral trioxide aggregate TARGET Mineral trioxide aggregate Universidad de los Andes, Chile marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mineral trioxide aggregate — Competitive Intelligence Brief. https://druglandscape.com/ci/mineral-trioxide-aggregate. Accessed 2026-05-20.

Build your own brief

Pick any drug + add comparators: